BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Alere Inc. (ALR) and AT&T Team Up to Tackle Diabetes


8/9/2012 10:34:07 AM

ATLANTA and DALLAS, Aug. 8, 2012 /PRNewswire/ -- Diabetes is a major cause of heart disease and stroke, and the leading cause of kidney failure. It's a condition that impacts nearly 26 million people in the U.S., or 8.3 percent of the population, and, if current trends continue, as many as 1 in 3 U.S. adults could have diabetes by 2050.1 That's why Alere Health, LLC, and AT&T* are teaming up to provide patients with a better way to manage and control their diabetes.

The companies will jointly deliver DiabetesManager®, an end-to-end mobile health (mHealth) diabetes solution powered by WellDoc® that will help adults with type 2 diabetes manage their health and engage with their caregivers. Alere Health, a division of Alere Inc. and a leading provider of personal health support solutions, and the largest U.S. provider of specialized, patient-centered health management services, currently manages over 290,000 individuals with diabetes.

This solution will complement Alere's mHealth solution portfolio, enabling a more dynamic and personalized approach for the engagement and participation of members diagnosed with diabetes. FDA-cleared DiabetesManager will be targeted for higher risk, higher acuity patients, in contrast to Alere's Mya solution that is designed for lower risk, lower acuity patients.

"There are hundreds of mHealth diabetes applications in the market today; however, this solution will be one of the first to be fully connected to a clinical system as part of an integrated plan of care," said Mike Cotton, CEO of Alere Health. "It goes beyond providing real-time coaching to the patient and enables the valuable patient information collected to be shared with nurses, case workers and doctors, who can communicate directly with the patient if needed."

"This collaboration combines best-in-class healthcare management services from Alere with best-in-class technology solutions from AT&T," said Randall Porter, Assistant Vice President, AT&T ForHealthSM, AT&T Business Solutions. "The innovative mHealth solution connects patients to Alere's care managers to help promote behavior that can lead to healthier outcomes."

The companies will jointly market and sell the solution to health plans, insurers and corporate payers. The solution will be part of Alere's care management portfolio and is expected to be available in the third quarter.

How it Works:

Members enter blood glucose readings and medication data into DiabetesManager on their compatible mobile device or the web and receive real-time feedback regarding their blood glucose control and immediate, recommended next step actions. The solution will be integrated with the Alere advanced clinical care management system, Apollo, to provide active, clinically based care management, with live clinicians available 24/7.

1Centers for Disease Control and Prevention.

*AT&T products and services are provided or offered by subsidiaries and affiliates of AT&T Inc. under the AT&T brand and not by AT&T Inc.

About Alere

Alere Health is the health management services business of Alere Inc. Alere, a Latin verb, meaning "to care for" or "to support," offers the most patient-centered health management services available from a single provider in the industry. Alere provides health interventions that cover an individual's entire lifespan, from pre-cradle to end-of-life care, and the company's services range from wellness and prevention to the total health management of individuals with chronic illnesses. Alere's continuum of services begins with preconception, pregnancy, NICU and first year of life; it continues with lifelong programs focused on health, wellness, the management of such conditions as heart failure, COPD, and asthma, and the complex management required for end-of-life care. For more information regarding Alere, please visit www.alere.com.

About AT&T

AT&T Inc. (NYSE:T) is a premier communications holding company and one of the most honored companies in the world. Its subsidiaries and affiliates AT&T operating companies are the providers of AT&T services in the United States and around the world. With a powerful array of network resources that includes the nation's fastest mobile broadband network, AT&T is a leading provider of wireless, Wi-Fi, high speed Internet, voice and cloud-based services. A leader in mobile broadband and emerging 4G capabilities, AT&T also offers the best wireless coverage worldwide of any U.S. carrier, offering the most wireless phones that work in the most countries. It also offers advanced TV services under the AT&T U-verse® and AT&T DIRECTV brands. The company's suite of IP-based business communications services is one of the most advanced in the world.

Additional information about AT&T Inc. and the products and services provided by AT&T subsidiaries and affiliates is available at http://www.att.com. This AT&T news release and other announcements are available at http://www.att.com/newsroom and as part of an RSS feed at www.att.com/rss. Or follow our news on Twitter at @ATT.

© 2012 AT&T Intellectual Property. AT&T and AT&T logo are trademarks of AT&T Intellectual Property. All rights reserved. Mobile broadband not available in all areas. AT&T, the AT&T logo and all other marks contained herein are trademarks of AT&T Intellectual Property and/or AT&T affiliated companies. All other marks contained herein are the property of their respective owners.

Alere is a trademark of the Alere group of companies.

WellDoc, the WellDoc logo, DiabetesManager and the DiabetesManager logo are trademarks of WellDoc, Inc. Use of the WellDoc and DiabetesManager names, the WellDoc and DiabetesManager logos, and certain information contained herein is pursuant to a license granted by WellDoc, Inc. All rights reserved. DiabetesManager® is manufactured by WellDoc, Inc., Baltimore, MD and distributed by AT&T Corp., Bedminster, NJ.

Cautionary Language Concerning Forward-Looking Statements

Information set forth in this press release contains financial estimates and other forward-looking statements that are subject to risks and uncertainties, and actual results might differ materially. A discussion of factors that may affect future results is contained in AT&T's filings with the Securities and Exchange Commission. AT&T disclaims any obligation to update and revise statements contained in this news release based on new information or otherwise.

SOURCE AT&T Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->